Skip to main content
Premium Trial:

Request an Annual Quote

GE's Reported Plans to Buy Abbott Dx Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Jan. 19.
 
1. GE Healthcare Said to Be Close to Acquiring Abbott Diagnostics In Further Dx Reorganization (from Jan. 18)
 
2. Abbott's Molecular Dx Unit Untouched as GE Plans to Buy In Vitro, POC Segments for $8B (from Jan. 19)
  
3. Cepheid and BioMerieux to Develop, Market Sepsis Assays (from Jan. 17)
 
4. ABI, BG Medicine Team on Industrial-Scale Biomarker Research (from Jan. 16)
 
5. Pfizer Buys Dx Rights to Genizon Research Programs, Takes Equity Stake in Firm (from Jan. 16) 
The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.